Kessler, RC, Adler, L, Barkley, R, Biederman, J, Conners, CK, Demler, O, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry
2006; 163: 716–23.
Simon, V, Czobor, P, Bálint, S, Mészáros, A, Bitter, I. Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br J Psychiatry
2009; 194: 204–11.
Conrad, P, Potter, D. From hyperactive children to ADHD adults: observations on the expansion of medical categories. Soc Prob
2000; 47: 559–82.
National Institute for Health and Clinical Excellence. Attention Deficit Hyperactivity Disorder: Diagnosis and Management of ADHD in Children, Young People and Adults (National Clinical Practice Guideline Number 72). NICE, 2008.
American Psychiatric Association. Proposed Revisions to the Diagnostic and Statistical Manual. APA, 2010.
Kooij, SJ, Bejerot, S, Blackwell, A, Caci, H, Casas-Brugue, M, Carpentier, PJ, et al. European consensus statement on diagnosis and treatment of adult ADHD: The European Network. Adult ADHD. BMC Psychiatry
2010; 10: 67.
Wong, IC, Asherson, P, Bilbow, A, Clifford, S, Coghill, D, DeSoysa, R, et al. Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY) – a pharmacoepidemiological and qualitative study. Health Technol Assess
2009; 13: iii–xi, 1–120.
Taylor, N, Fauset, A, Harpin, V. Young adults with ADHD: an analysis of their service needs on transfer to adult services. Arch Dis Child
2010; 95: 513–7.
Shaffer, D. Attention deficit hyperactivity disorder in adults. Am J Psychiatry
1994; 151: 633–8.
Arria, AM, Caldeira, KM, O'Grady, KE, Vincent, KB, Johnson, EP, Wish, ED. Nonmedical use of prescription stimulants among college students: associations with attention-deficit-hyperactivity disorder and polydrug use. Pharmacotherapy
2008; 28: 156–69.
NHS Information Centre. Prescription Cost Analysis, England – 2009. The Information Centre, 2010.
Castle, L, Aubert, RE, Verbrugge, RR, Khalid, M, Epstein, RS. Trends in medication treatment for ADHD. J Atten Disord
2007; 10: 335–42.
Harris, G, Carey, B. Researchers fail to reveal full drug pay. New York Times
2008; 8 June.
Talking Back to Ritalin: What Doctors aren't Telling You about Stimulants and ADHD. Perseus Publishing, 2001.
Timimi, S, Moncrieff, J, Jureidini, J, Leo, J, Cohen, D, Whitfield, C, et al. A critique of the international consensus statement on ADHD. Clin Child Fam Psychol Rev
2004; 7: 59–63.
Naughty Boys: Anti-Social Behaviour, ADHD and the Role of Culture. Palgrave Macmillan, 2005.
Conners, CK, Erhardt, D, Sparrow, E.
Conners' (CAARS) Adult ADHD Rating Scales – Technical Manual. Multi-Health Systems, 1999.
Brown, TE. Brown Attention-Deficit Disorder Scales (Manual). Psychological Corporation, 1996.
Kinsbourne, M. Minimal brain dysfunction as a neurodevelopmental lag. Ann NY Acad Sci
1973; 205: 268–73.
Hill, JC, Schoener, EP. Age-dependent decline of attention deficit hyperactivity disorder. Am J Psychiatry
1996; 153: 1143–6.
Shaw, P, Eckstrand, K, Sharp, W, Blumenthal, J, Lerch, JP, Greenstein, D, et al. Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation. Proc Natl Acad Sci USA
2007; 104: 19649–54.
Faraone, SV, Biederman, J, Mick, E. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med
2006; 36: 159–65.
McGough, JJ, Smalley, SL, McCracken, JT, Yang, M, Del'Homme, M, Lynn, DE, et al. Psychiatric comorbidity in adult attention deficit hyperactivity disorder: findings from multiplex families. Am J Psychiatry
2005; 162: 1621–7.
de Graaf, R, Kessler, RC, Fayyad, J, ten Have, M, Alonso, J, Angermeyer, M, et al. The prevalence and effects of adult attention-deficit/hyperactivity disorder (ADHD) on the performance of workers: results from the WHO World Mental Health Survey Initiative. Occup Environ Med
2008; 65: 835–42.
Fried, R, Petty, CR, Surman, CB, Reimer, B, Aleardi, M, Martin, JM, et al. Characterizing impaired driving in adults with attention-deficit/hyperactivity disorder: a controlled study. J Clin Psychiatry
2006; 67: 567–74.
Biederman, J, Petty, C, Fried, R, Fontanella, J, Doyle, AE, Seidman, LJ, et al. Impact of psychometrically defined deficits of executive functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry
2006; 163: 1730–8.
Asherson, P, Adamou, M, Bolea, B, Muller, U, Morua, SD, Pitts, M, et al. Is ADHD a valid diagnosis in adults? Yes. BMJ
2010; 340: c549.
Frodl, T, Stauber, J, Schaaff, N, Koutsouleris, N, Scheuerecker, J, Ewers, M, et al. Amygdala reduction in patients with ADHD compared with major depression and healthy volunteers. Acta Psychiatr Scand
2010; 121: 111–8.
Seidman, LJ, Biederman, J, Liang, L, Valera, EM, Monuteaux, MC, Brown, A, et al. Gray matter alterations in adults with attention-deficit/hyperactivity disorder identified by voxel based morphometry. Biol Psychiatry
2011; 69: 857–66.
Perlov, E, Philipsen, A, van Elst, LT, Ebert, D, Henning, J, Maier, S, et al. Hippocampus and amygdala morphology in adults with attention-deficit hyperactivity disorder. J Psychiatry Neurosci
2008; 33: 509–15.
Arnsten, AF. Stimulants: therapeutic actions in ADHD. Neuropsychopharmacology
2006; 31: 2376–83.
Jensen, PS, Arnold, LE, Swanson, JM, Vitiello, B, Abikoff, HB, Greenhill, LL, et al. 3-year follow-up of the NIMH MTA study. J Am Acad Child Adolesc Psychiatry
2007; 46: 989–1002.
Koesters, M, Becker, T, Kilian, R, Fegert, JM, Weinmann, S. Limits of meta-analysis: methylphenidate in the treatment of adult attention-deficit hyperactivity disorder. J Psychopharmacol
2009; 23: 733–44.
Gualtieri, CT, Ondrusek, MG, Finley, C. Attention deficit disorders in adults. Clin Neuropharmacol
1985; 8: 343–56.
Medori, R, Ramos-Quiroga, JA, Casas, M, Kooij, JJ, Niemela, A, Trott, GE, et al. A randomized, placebo-controlled trial of three fixed dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry
2008; 63: 981–9.
Adler, LA, Zimmerman, B, Starr, HL, Silber, S, Palumbo, J, Orman, C, et al. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study. J Clin Psychopharmacol
2009; 29: 239–47.
Adler, A, Spencer, TJ, Levine, LR, Ramsey, JL, Tamura, R, Kelsey, D, et al. Functional outcomes in the treatment of adults with ADHD. J Atten Disord
2008; 11: 720–7.
Healy, D. Shaping the intimate: influences on the experience of everyday nerves. Soc Stud Sci
2004; 34: 219–45.
Women's Madness: Misogyny or Mental Illness?
University of Massachusetts Press, 1991.
Sumnall, HR, Woolfall, K, Cole, J, Mackridge, A, McVeigh, J. NICE guidance on ADHD: diversion and abuse of methylphenidate in light of new guidance. BMJ
2008; 337: a2287.
Government of Western Australia. Australian Secondary Students Alcohol and Drug Survey 2005, Summary of Western Australia Results (Report No. 37). Statistical Bulletin Number 37, Drug and Alcohol Office, Government of Western Australia, 2007.
Schubert, S, Hansen, S, Dyer, K, Rapley, M. ‘ADHD patient’ or ‘illicit drug user’? Managing medico-moral membership categories in drug dependence services. Discourse Society
2009; 20: 499–516.
Williams, SJ, Martin, P. Risks and benefits may turn out to be finely balanced. Nature
2009; 457: 532.
Westover, AN, McBride, S, Haley, RW. Stroke in young adults who abuse amphetamines or cocaine: a population-based study of hospitalized patients. Arch Gen Psychiatry
2007; 64: 495–502.